A new antiviral drug that induces mutations in the genetic material of influenza virus is highly effective in treating influenza infection in animals and human airway tissue and could be a groundbreaking advance in influenza therapy, according to a study by the Institute for Biomedical Sciences at Georgia State University.
The antiviral drug blocks RNA polymerase, the enzyme that plays a central role in replicating the genome of influenza virus, causing mutations in the viral genome. If enough mutations occur, the genome becomes nonfunctional and the virus cannot replicate. The findings were published online on Oct. 23 in Science Translational Medicine.
“The compound is highly efficacious against influenza,” said Dr. Richard Plemper, senior author of the study and a professor in the Institute for Biomedical Sciences. “It’s orally available, it’s broad spectrum against all influenza virus strains tested, and most important it establishes a high barrier against viral escape from inhibition.”
Influenza, caused by a contagious respiratory virus, is characterized by fever, cough, headache, muscle and joint pain, severe malaise, sore throat and sometimes gastrointestinal symptoms. Patients in higher risk groups, such as older adults and individuals with compromised immune systems, frequently require hospitalization. Each year, seasonal influenza results in 30,000 to 80,000 fatalities in the United States. The seasonal flu vaccine is only moderately effective, and licensed antivirals are compromised by rapidly emerging viral resistance to the drugs.
In the study, the new antiviral drug was tested in ferrets, the most informative animal model for human influenza disease, against various strains that include seasonal and pandemic viruses, such as the swine-origin influenza virus responsible for a 2009 pandemic. The researchers found that the antiviral drug efficiently inhibited replication of all of these strains. Virus burden dropped rapidly after treatment, and the duration of fever was significantly shorter in treated ferrets than in control animals that did not receive the drug.
“We think that the next generation of influenza antiviral drugs must not only be efficacious and safe, but also address the resistance problem,” said Dr. Mart Toots, first author of the study and a research assistant professor associated with Dr. Plemper’s lab in the Institute for Biomedical Sciences.
That is where the new drug comes in. Through a combination of conventional and ultra-deep sequencing, Toots has demonstrated in collaboration with Dr. Alex Greninger at the University of Washington that it is very challenging for the virus to find a viable way to avoid the compound.
“We have not identified specific resistance mutations yet and are confident to say that the genetic barrier against viral resistance is high,” Plemper said. “We believe that this compound has high clinical potential as a next-generation influenza drug that combines key antiviral features.”
The Latest on: Influenza
via Google News
The Latest on: Influenza
- Vanuatu denies entry to cruise ship following influenza diagnoseson February 28, 2020 at 4:00 pm
The Voyager of the Seas has been forced to abandon its planned trip through the Pacific Islands after three staff members were diagnosed with influenza and the cruise ship was denied entry to Vanuatu.
- Dominican Republic Turns Back Cruise Ship Over 'Influenza-Like Cases' Reported on Boardon February 28, 2020 at 12:18 pm
Fred. Olsen Cruise Lines said in an emailed statement that it had reported “a small number of influenza-like cases on board. Our medical team has now advised that they are all feeling better. No ...
- Recommended composition of influenza virus vaccines for use in the 2020 - 2021 northern hemisphere influenza seasonon February 28, 2020 at 8:46 am
It is recommended that trivalent influenza vaccines for use in the 2020 - 2021 northern hemisphere influenza season contain the following: Egg-based Vaccines an A/Guangdong-Maonan/SWL1536/2019 ...
- Marshfield Clinic prepares for potential coronavirus outbreak, warns about influenzaon February 27, 2020 at 8:55 pm
President Trump has made it clear that the United States is prepared for a possible coronavirus outbreak, announcing that Vice President Mike Pence will head a task force aimed at preventing the ...
- Infectious diseases A-Z: Influenza's second waveon February 27, 2020 at 9:42 am
Influenza A is currently the dominant strain of influenza circulation, but the flu season didn't start that way. "Similar to last year, we have seen two waves of influenza," says Dr. Nipunie Rajapakse ...
- Richland School District cancels classes due to Influenza A outbreakon February 27, 2020 at 7:25 am
Classes are canceled for the entire Richland School District on Thursday due to the spread of Influenza A, officials tell NBC15 News.
- Treasure Coast sees mild influenza activity; health officials encourage vaccinationon February 26, 2020 at 5:04 pm
Treasure Coast sees mild influenza activity; health officials encourage vaccination Influenza activity in Indian River, St. Lucie and Martin counties is higher than previous years, but mild, health ...
- Rise In Flu Deaths Make Americans Worry More About Influenza Than Coronaviruson February 25, 2020 at 2:17 am
Amidst the recent coronavirus outburst, the number of flu deaths increased in Georgia for the second week in a row. According to a new poll conducted by The Associated Press-NORC Center for Public ...
- Influenza Vaccines Global Market- Regional Trends, Industry Demand, Comprehensive Analysis and Forecast to 2025on February 25, 2020 at 1:11 am
Global Influenza Vaccination Market – Overview Influenza is a contagious respiratory disease which affects the ...
- Researchers analyze influenza epidemiologic supervision and children cases in Cataloniaon February 24, 2020 at 12:42 pm
The viral infections of the upper respiratory tract are an important cause of morbidity and mortality worldwide and, among them, influenza is one of the most important ones, with severe cases ranging ...
via Bing News